But even with that long list of upsides, there’s still one pesky side effect many struggle with while taking a GLP-1: muscle loss. Research shows that while these drugs can be highly effective for ...

Although lean body mass (including muscle) also decreases to a lesser degree, the result is still a more favorable overall body composition. Any significant weight loss (from dietary changes, ...

In the battle of the obesity bulge, glucagon-like peptide-1 receptor agonist medications — aka GLP-1s such as Wegovy and Zepbound — have changed the game for some people who’ve struggled to lose ...

GLP-1 drugs have been accused of stealing muscle along with fat, but the evidence suggests the scare may say more about sloppy measurement than about biology. A new study finds that much of the ...

The use of GLP-1 medications for weight loss continues to rise. One drawback associated with GLP-1 medications is that weight loss not only includes fat loss, but muscle loss as well. A new study ...

FITCHBURG, Mass., June 10, 2026 /PRNewswire/ -- Millions of Americans are turning to GLP-1 medications such as Zepbound®, Wegovy® and Ozempic® to lose weight. In fact, a recent KFF Health Tracking ...

GLP-1 medications like Ozempic and Wegovy are changing the conversation around weight loss. And to be clear, they work. Clinical data shows users can lose significant body weight, often in the 10 to ...

Drugs from the GLP-1 receptor agonist class, widely used for diabetes and weight loss, are now under scrutiny for their potential impact on muscle health in vulnerable patients. A new study published ...

Vienna — The investigational monoclonal antibody trevogrumab was associated with lean mass preservation and greater loss of fat mass in people taking semaglutide, an interim trial data showed.

Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss. But along with the fat, many are quietly losing something else: muscle. Unlike fat, muscle doesn ...

Bariatric surgery patients and GLP-1 medication users had fat-mass reductions of 49.7% and 18%, respectively, after 2 years. Surgery led to higher fat-free mass to fat-mass ratios, suggesting more ...

Jenn Glass has been taking a GLP-1 since last November. The 53-year-old mother of three has already lost more than 30 pounds, but she's focused on something beyond the number on the scale. WCCO joined ...